AdaptHealth swings to Q3 net loss of $168.2 million; Q3 net revenue rises 11% to $745.6 million

• AdaptHealth swung to a third-quarter net loss of $168.2 million, largely due to a $184.8 million pre-tax goodwill write-down.
• Net revenue rose 11% year over year to $745.6 million.
• The pending $235 million cash sale of its Diabetes Health business remains on track to close in early 2027.
• FY26 net revenue guidance increased to $2.88 billion-$2.9 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AdaptHealth Corp. published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.